Loading organizations...
§ Private Profile · San Diego, CA, USA
Genomics-based health intelligence company applying machine learning to fight aging-related diseases and enable proactive healthcare.
Human Longevity, a genomics-based health intelligence company based in San Diego, California, builds comprehensive databases of human genotypes and phenotypes, applying machine learning to fight aging-related diseases and enable proactive healthcare. The company has raised approximately $330 million across multiple financing rounds, including an $80 million Series A in 2014, a $220 million Series B in 2016, and $30 million in 2019. It operates precision medicine clinics, such as the Health Nucleus, in San Diego, San Francisco, and Beijing, offering individualized health insights and has published over 20 peer-reviewed papers. Human Longevity partners with pharmaceutical companies like Celgene and AstraZeneca for research collaboration and data sales. Key figures associated with the company include Executive Chairman Wei-Wu He and former CEO Cynthia Collins. Human Longevity was founded in 2013 by J. Craig Venter, Robert Hariri, and Peter Diamandis.
Human Longevity has raised $250.0M across 2 funding rounds.
Human Longevity has raised $250.0M in total across 2 funding rounds.
Human Longevity has raised $250.0M across 2 funding rounds. Most recently, it raised $30.0M Other Equity in November 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 6, 2019 | $30M Venture Round | — | Emerging Technology Partners | Announced |
| Apr 4, 2016 | $220M Series B | — | Celgene, GE Ventures, Illumina | Announced |
Human Longevity has raised $250.0M in total across 2 funding rounds.
Human Longevity's investors include Emerging Technology Partners, Celgene, GE Ventures, Illumina.